Related Experiment Video
Updated: Dec 29, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Novel therapeutic targets for cancer metastasis
Konstantin Stoletov1, Perrin H Beatty1, John D Lewis1
1Department of Oncology, University of Alberta, Edmonton, Canada.
Abstract:
Introduction: Metastatic cancers are extremely difficult to treat, and account for the vast majority of cancer-related deaths. The dissemination of tumor cells to distant sites is highly dynamic, asynchronous, and involves both tumor and host intrinsic factors. Effective therapeutic targets to block metastasis will need to disrupt key pathways that are required for multiple stages of metastasis.Areas covered: This review discusses the heterogeneity of cancers and metastasis, with an emphasis on motility as a key driver trait of metastasis. Recent metastatic cancer studies that identified either host or cancer cell intrinsic factors important for metastasis, using single gene-deficient animal models or 3D intravital imaging of avian embryo models, are also discussed. Potential metastatic blocking targets are listed as they relate to metastatic cancer therapy.Expert opinion: The development of metastatic disease is a complex interplay of genetic and epigenetic factors from the host and cancer cells acting in a patient-specific manner. Inhibiting key driver traits of metastasis should yield survival benefit at any stage of the disease, and we look forward to the next generation of personalized medicines for cancer therapy that target cancer cell motility for increased therapeutic efficacy.
Insights
Metastatic cancers are difficult to treat, causing most cancer deaths. Targeting cancer cell motility offers a promising strategy for developing new therapies to block cancer spread and improve patient survival.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Metastatic cancers are a leading cause of cancer-related mortality.
- Tumor cell dissemination is a complex process influenced by tumor and host factors.
- Blocking metastasis requires targeting key pathways essential for multiple metastatic stages.
Purpose of the Study:
- To review cancer and metastasis heterogeneity.
- To emphasize cancer cell motility as a critical driver trait in metastasis.
- To discuss recent findings and potential therapeutic targets for blocking metastasis.
Main Methods:
- Review of recent metastatic cancer studies.
- Analysis of single gene-deficient animal models.
- Utilization of 3D intravital imaging in avian embryo models.
Main Results:
- Identified host and cancer cell intrinsic factors crucial for metastasis.
- Highlighted the importance of cancer cell motility.
- Listed potential targets for metastatic blocking therapies.
Conclusions:
- Metastatic disease development involves complex host and cancer cell interactions.
- Targeting key metastasis driver traits, like motility, can improve survival.
- Future personalized medicines should focus on cancer cell motility for enhanced efficacy.
More Related Videos
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
07:00Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
Published on: September 26, 2016
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: